Currently, there are 3.06B common shares owned by the public and among those 3.02B shares have been available to trade.
The company’s stock has a 5-day price change of 1.49% and 18.51% over the past three months. SHEL shares are trading 14.97% year to date (YTD), with the 12-month market performance up to 7.75% higher. It has a 12-month low price of $60.15 and touched a high of $74.61 over the same period. SHEL has an average intraday trading volume of 4.31 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.15%, 7.13%, and 5.91% respectively.
Institutional ownership of Shell Plc ADR (NYSE: SHEL) shares accounts for 12.61% of the company’s 3.06B shares outstanding.
It has a market capitalization of $217.28B and a beta (3y monthly) value of 0.28. The stock’s trailing 12-month PE ratio is 14.36, while the earnings-per-share (ttm) stands at $5.01. The company has a PEG of 3.10 and a Quick Ratio of 1.10 with the debt-to-equity ratio at 0.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.12% over the week and 1.55% over the month.
Analysts forecast that Shell Plc ADR (SHEL) will achieve an EPS of 1.71 for the current quarter, 1.78 for the next quarter and 7.7 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.46 while analysts give the company a high EPS estimate of 1.46. Comparatively, EPS for the current quarter was 2.4 a year ago. Earnings per share for the fiscal year are expected to decrease by -4.64%, and 8.82% over the next financial year. EPS should shrink at an annualized rate of 4.64% over the next five years, compared to 5.38% over the past 5-year period.
Looking at the support for the SHEL, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on March 19, 2025, with the firm’s price target at $81. Morgan Stanley was of a view on January 07, 2025 that the stock is Overweight, while Wolfe Research gave the stock Outperform rating on January 03, 2025, issuing a price target of $80. Wolfe Research on their part issued Peer Perform rating on July 18, 2024.
